Related Experiment Video

Updated: Aug 15, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Obesity-associated mutations in the human melanocortin-4 receptor gene

Robert G MacKenzie1

  • 1Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3228 Scott Hall, 540 E. Canfield, Detroit, MI 48201, USA. rmackenz@med.wayne.edu

Peptides
|November 9, 2005
PubMed

Insights

Mutations in the melanocortin-4 receptor (MC4R) gene are linked to severe obesity. This review explores MC4R

Area of Science:

  • Endocrinology and Metabolism
  • Genetics and Genomics
  • Neuroscience

Background:

  • The melanocortin-4 receptor (MC4R) is crucial for regulating body weight centrally.
  • Mutations in the MC4R gene are a significant genetic cause of severe obesity.
  • Understanding MC4R function is key to addressing metabolic disorders.

Purpose of the Study:

  • To review the role of MC4R in the central regulation of body weight.
  • To discuss the pathogenic mechanisms underlying MC4R mutations.
  • To evaluate MC4R as a therapeutic target for obesity.

Main Methods:

  • Literature review of studies on MC4R genetics and function.
  • Analysis of mutation types and their impact on receptor activity.
  • Assessment of MC4R signaling pathways in obesity pathogenesis.

Main Results:

  • MC4R mutations frequently lead to partial or complete loss-of-function.
  • Heterologous expression systems are used to characterize mutant MC4R phenotypes.
  • Evidence supports MC4R's critical role in energy homeostasis.

Conclusions:

  • MC4R is a validated target for anti-obesity therapies.
  • Further research into MC4R modulation may yield novel treatments for obesity.
  • Genetic variations in MC4R offer insights into obesity etiology.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...